Menu
Back to User profile » Professor Maling Gou
Papers published by Professor Maling Gou:
Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
Liu J, Yang L, Yuan X, Xiong M, Zhu J, Wu W, Ren M, Long J, Xu X, Gou M
International Journal of Nanomedicine 2021, 16:7697-7709
Published Date: 17 November 2021
Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor
Sui M, Xiong M, Li Y, Zhou Q, Shen X, Jia D, Gou M, Sun Q
International Journal of Nanomedicine 2021, 16:2833-2847
Published Date: 14 April 2021
Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M
International Journal of Nanomedicine 2020, 15:9669-9670
Published Date: 2 December 2020
Targeted nanoparticle-mediated LHPP for melanoma treatment
Zhang Q, Xiong M, Liu J, Wang S, Du T, Kang T, Liu Y, Cheng H, Huang M, Gou M
International Journal of Nanomedicine 2019, 14:3455-3468
Published Date: 10 May 2019
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
Kang T, Li C, Du T, Wu Y, Yang Y, Liu X, Zhang Q, Xu X, Gou M
International Journal of Nanomedicine 2018, 13:3251-3261
Published Date: 1 June 2018
Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
Jin X, Zhang P, Luo L, Cheng H, Li Y, Du T, Zou B, Gou M
International Journal of Nanomedicine 2016, 11:4535-4544
Published Date: 8 September 2016
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
Jin X, Zou B, Luo L, Zhong C, Zhang P, Cheng H, Guo Y, Gou M
International Journal of Nanomedicine 2016, 11:4545-4552
Published Date: 8 September 2016
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M
International Journal of Nanomedicine 2016, 11:501-513
Published Date: 2 February 2016